ALK and T-cell non-Hodgkin lymphoma: Except for ALK positive anaplastic large cell lymphoma, T-cell lymphoma responds to conventional chemotherapy unfavourably, and most patients carry poor prognosis.In recent years, efforts have been made to improve the outcome of T-cell lymphoma patients.